Fortress Biotech among healthcare gainers; Novelion Therapeutics leads losers

|By:, SA News Editor

Gainers: Solid Biosciences (NASDAQ:SLDB) +20%. Fortress Biotech (NASDAQ:FBIO) +14%. Unum Therapeutics (NASDAQ:UMRX+15%. Daxor (NYSEMKT:DXR+14%. Trinity Biotech (NASDAQ:TRIB) +13%.

Losers: Novelion Therapeutics (NASDAQ:NVLN) -14%. Viveve Medical (NASDAQ:VIVE) -10%. CymaBay Therapeutics (NASDAQ:CBAY) -9%. Madrigal Pharmaceuticals (NASDAQ:MDGL) -8%. Valeritas Holdings (NASDAQ:VLRX-7%.

Subscribe for full text news in your inbox